The Global Health Group has developed a close collaboration with Wilton Park. Since 2002 the Global Health Group has co-hosted 10 global health conferences at Wilton Park—the prestigious conference and retreat venue of the British Foreign and Commonwealth Office. These conferences take on a broad array of global health issues and are organized in partnership with a wide range of technical, policy and funding partners. Topics have included malaria and health systems (including two seminal meetings on public-private integrated partnerships) – but also areas beyond the immediate focus of the Global Health Group.
|The New Era in HIV/AIDS Treatment and Prevention: Science, Implementation and Finance (WB1170)||June 2012|
This high level meeting organized by Wilton Park in partnership with Sir Richard Feachem, Director of The Global Health Group, University of California, and Gilead Sciences, was held in France, near Geneva, during June 2012.
Lead scientists, heads of development and technical agencies, representatives from governments, national programmes and civil society gathered to debate cutting edge scientific developments, and their implications for saving lives in HIV/AIDS programmes in developing countries.
|Malaria: Integrating New Tools for Zero Deaths and Elimination (WP1141)||February 2012|
The Global Health Group co-hosted a meeting to debate the uses and implementation implications for new malaria tools, such as the promising RTS,S malaria vaccine candidate. This influential meeting of malaria stakeholders and country representatives has led to more candid discussions about how a malaria vaccine may be incorporated into malaria programs in the near future, as well as how current malaria tools can be currently optimized.
GlaxoSmithKline, Medicines for Malaria Venture, Novartis, PATH Malaria Vaccine Initiative and Vestegaard Frandsen also provided conference support.
|Financing Continued Scale-up in HIV Treatment: More Money for Years Gained and More Years Gained for the Money (WP1091)||February 2011|
The Global Health Group partnered with Gilead Sciences to host a meeting to debate the growing gap between the availability of national and international finance for antiretroviral therapy and the need for such treatment demonstrated by new scientific findings. This influential meeting of ministers and agency leaders has led to more honest debate between donor and recipient governments concerning the future finance for HIV/AIDS treatment.
|Public-Private Investment Partnerships in Health Systems Strengthening (WP1045)||September 2010|
|Malaria: Getting to Zero (WP967)||April 2009|
|Public-Private Investment Partnerships for Health (PPIPs): Innovations for Quality and Efficiency in Health Systems (WP909)||April 2008|
|Innovations in Health and Development Finance: Lessons Learned and the Way Forward (WPS06/11)||December 2006|
|Improving the Effectiveness of Health Investments in Developing Countries (WP785)||June 2005|
|Scaling up Health Investments in Developing Countries: Lessons about What Works (WP751)||June 2004|
|Financing Global Public Goods for Health (WP714)||June 2003|
|Investing in Health for Economic Growth and Poverty Reduction: New Perspectives and Opportunities (WP674)||May 2002|